The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer
Abstract
Share and Cite
Bartnykaitė, A.; Savukaitytė, A.; Bekampytė, J.; Ugenskienė, R.; Laukaitienė, D.; Korobeinikova, E.; Gudaitienė, J.; Juozaitytė, E. The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer. Biomedicines 2022, 10, 1891. https://doi.org/10.3390/biomedicines10081891
Bartnykaitė A, Savukaitytė A, Bekampytė J, Ugenskienė R, Laukaitienė D, Korobeinikova E, Gudaitienė J, Juozaitytė E. The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer. Biomedicines. 2022; 10(8):1891. https://doi.org/10.3390/biomedicines10081891
Chicago/Turabian StyleBartnykaitė, Agnė, Aistė Savukaitytė, Justina Bekampytė, Rasa Ugenskienė, Danguolė Laukaitienė, Erika Korobeinikova, Jurgita Gudaitienė, and Elona Juozaitytė. 2022. "The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer" Biomedicines 10, no. 8: 1891. https://doi.org/10.3390/biomedicines10081891
APA StyleBartnykaitė, A., Savukaitytė, A., Bekampytė, J., Ugenskienė, R., Laukaitienė, D., Korobeinikova, E., Gudaitienė, J., & Juozaitytė, E. (2022). The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer. Biomedicines, 10(8), 1891. https://doi.org/10.3390/biomedicines10081891

